Reply to Gamaldo and McArthur

Nancy F. Crum-Cianflone; David J. Moore; Braden Hale; Brian K. Agan; Scott Letendre

doi:10.1093/cid/cis702

Reply to Gamaldo and McArthur

Nancy F. Crum-Cianflone^*
, David J. Moore
, Braden Hale
, Brian K. Agan
, Scott Letendre

^*Corresponding author for this work

Infectious Disease Clinical Research Program (IDCRP)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1430-1431
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	55
Issue number	10
DOIs	https://doi.org/10.1093/cid/cis702
State	Published - Nov 2012

Access to Document

10.1093/cid/cis702

Cite this

@article{5a75cbf315e445779dfd670b26fc815a,

title = "Reply to Gamaldo and McArthur",

author = "Crum-Cianflone, \{Nancy F.\} and Moore, \{David J.\} and Braden Hale and Agan, \{Brian K.\} and Scott Letendre",

note = "Funding Information: ceived a grant from the Henry M. Jackson Foundation, and has grants pending from the National Institutes of Health, California HIV/ AIDS Research Program, and Merck. S. L. is a consultant for GlaxoSmithKline, Gilead, and Merck; has grants pending from Abbott Labs, Merck, GlaxoSmithKline, and Tibotec; and is on the speakers{\textquoteright} bureau for Abbott Labs. All other authors report no potential conflicts.",

year = "2012",

month = nov,

doi = "10.1093/cid/cis702",

language = "English",

volume = "55",

pages = "1430--1431",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Reply to Gamaldo and McArthur

AU - Crum-Cianflone, Nancy F.

AU - Moore, David J.

AU - Hale, Braden

AU - Agan, Brian K.

AU - Letendre, Scott

N1 - Funding Information: ceived a grant from the Henry M. Jackson Foundation, and has grants pending from the National Institutes of Health, California HIV/ AIDS Research Program, and Merck. S. L. is a consultant for GlaxoSmithKline, Gilead, and Merck; has grants pending from Abbott Labs, Merck, GlaxoSmithKline, and Tibotec; and is on the speakers’ bureau for Abbott Labs. All other authors report no potential conflicts.

PY - 2012/11

Y1 - 2012/11

UR - https://www.scopus.com/pages/publications/84868033724

U2 - 10.1093/cid/cis702

DO - 10.1093/cid/cis702

M3 - Letter

AN - SCOPUS:84868033724

SN - 1058-4838

VL - 55

SP - 1430

EP - 1431

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -